DCF — BILLINGS CLINIC
Enterprise Value: $-2.3B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-2.3B
Enterprise Value
$-699.0M
PV of Cash Flows
$-1.6B
PV of Terminal Value
$-2.5B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $897.6M | $-150.6M | -17.0% | $-188.6M | $-171.5M |
| Year 2 | $924.6M | $-145.9M | -16.0% | $-185.0M | $-152.9M |
| Year 3 | $952.3M | $-140.7M | -15.0% | $-181.1M | $-136.0M |
| Year 4 | $980.9M | $-140.1M | -14.0% | $-181.6M | $-124.0M |
| Year 5 | $1.0B | $-141.7M | -14.0% | $-184.5M | $-114.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-2.3B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$871.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.17278695606774977
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5